John D Buynak

USPTO Granted Patents = 21 (Patent Applications = 2)

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 49(Granted Patents)

Company Filing History:

11 out of 366

Research Corporation Technologies, Inc.

patents

8 out of 116

Southern Methodist University

patents

2 out of 1,310

University of Central Florida Research Foundation, Inc.

5. 1 out of 832,812

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2022

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11234966 - C5-substituted carbapenem antibiotics, compositions containing such compounds, and methods of use in treatment of mycobacterium tuberculosis and non-tubercular mycobacteria (2022-02-01),

2. 10702501 - C5-substituted carbapenem antibiotics, compositions containing such compounds, and methods of use in treatment ofand non-tubercular mycobacteria (2020-07-07),

3. 10519161 - Methods of generating beta-lactamase resistant carbapenem compounds (2019-12-31),

4. 8575144 - Beta-lactamase inhibitory compounds (2013-11-05),

5. 8299051 - Beta-lactamase inhibitory compounds (2012-10-30),

6. 7488724 - 7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors (2009-02-10),

7. 7125986 - Penicillanic acid derivative compounds and methods of making (2006-10-24),

8. 7022691 - Inhibitors of serine and metallo-β-lactamases (2006-04-04),

9. 6916801 - 7-Alkylidene-3-substituted-3-cephem-4-carboxylates as β-lactamase inhibitors (2005-07-12),

10. 6906054 - Compositions for inhibiting beta-lactamase (2005-06-14),

11. 6770759 - Penicillanic acid derivative compounds and methods of making (2004-08-03),

12. 6599892 - 7-alkylidene cephalosporanic acid derivatives and methods of using the same (2003-07-29),

13. 6436398 - 2 &bgr;-substituted-6-alkylidene penicillanic acid derivatives as &bgr;-lactamase inhibitors (2002-08-20),

14. 6407091 - &bgr;-lactamase inhibiting compounds (2002-06-18),

15. 6303592 - 7-alkylidene cephalosporanic acid derivatives and methods of using the same (2001-10-16),

Sure, here is the article:

Title: The Inventor John D Buynak: A Pioneer in Antibiotic Innovations

Introduction:

John D Buynak, a distinguished inventor based in Dallas, TX, has made significant contributions to the field of antibiotics with a total of 21 patents to his name.

Latest Patents:

Among his latest patents is the groundbreaking invention of C5-substituted carbapenem antibiotics. This invention encompasses a composition, method of making, and method of using a novel C5-substituted carbapenem antibiotic, which shows promise in the treatment of mycobacterium tuberculosis and non-tubercular mycobacteria.

Career Highlights:

John D Buynak has lent his expertise to renowned institutions such as Research Corporation Technologies, Inc. and Southern Methodist University, where he has played a pivotal role in shaping the landscape of antibiotic innovations.

Collaborations:

Throughout his career, John D Buynak has collaborated with esteemed professionals in the field, including Akireddy Srinivasa Rao and Venkata Ramana Doppalapudi, fostering a culture of innovation and excellence.

Conclusion:

In conclusion, John D Buynak's relentless pursuit of innovation in the realm of antibiotics underscores his commitment to advancing healthcare solutions. His numerous patents and collaborations stand as a testament to his remarkable contributions to the field.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

2 patents pending:

Please report any incorrect information to support@idiyas.com